Zhejiang Shouxiangu Pharm Co (603896) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Zhejiang Shouxiangu Pharm Co stock ¥4.55, price ¥13.45, that is 66.2% below the price, quality 45 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Zhejiang Shouxiangu Pharm Co
603896 · SHGFar too expensive (fair value 66% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range ¥12.95 – ¥56.07 · fair‑value band ¥2.44 – ¥6.46 · the ¥13.45 price screens above the ¥4.55 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Zhejiang Shouxiangu Pharm Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the selection, cultivation, processing, and sale of medicinal materials in China.
Show moreShow less
It offers Ganoderma lucidum spore powder and brand broken cell wall powder, as well as broken wall Ganoderma lucidum spore powder granules and powder tablets; Tiepi Fengdou granules; and Tiepi Fengdou Ganoderma lucidum extracts. The company offers its products under the Shouxiangu brand.
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Jinhua, China.
Stock analysis
Zhejiang Shouxiangu Pharm Co (603896) currently trades at ¥13.45, while our model-based Fair Value estimate is ¥4.55, 66% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ¥9.16 per share, and 2 of the 16 models we run sit above the ¥13.45 price.
Bear case: the Earnings-Based group reads lowest at ¥1.55, and 14 of the 16 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ¥2.44 (bear) to ¥6.46 (bull), the price of ¥13.45 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 45/100 (below-average quality), in the Healthcare sector.
Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Zhejiang Shouxiangu Pharm Co reported revenue of 640M CNY in FY2025 versus 767M CNY in FY2021, a compound −4.4%/yr. Reported net income was 18.2M CNY in FY2025, compounding −45.2%/yr from FY2021.
Key figures
Market cap 2.7B CNY (≈ $401M) Small · P/S ratio 4.41 · EPS (TTM) ¥−0.0500 · Dividend yield 2.2% · Net margin −1.7% · Return on equity −0.5% · Return on assets (EBIT) 7.6% (5-year average) · Operating margin 3.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (low confidence).
What moves the price
The share trades about 40% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −66%, 603896 screens richer than that median.
Fair Value models
All 16 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare Zhejiang Shouxiangu Pharm Co with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 847 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Consumer Staples sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Chinese Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $952.40 | $1,275 | +34% | vs 603896 |
| Vertex Pharmaceuticals Incorporated VRTX | $537.79 | $592.46 | +10% | vs 603896 |
| Samsung Biologics Co 207940 | 1,423,000 KRW | 1,552,100 KRW | +9% | vs 603896 |
| argenx SE ARGX | $950.95 | $908.40 | −4% | vs 603896 |
| CSL Limited CSL | A$199.55 | A$186.49 | −7% | vs 603896 |
| Moderna, Inc MRNA | $215.27 | $135.64 | −37% | vs 603896 |
| BeOne Medicines AG 6160 | HK$249.40 | HK$152.92 | −39% | vs 603896 |
| Revolution Medicines, Inc RVMD | $166.87 | $88.78 | −47% | vs 603896 |
| Celltrion, Inc 068270 | 214,500 KRW | 74,945 KRW | −65% | vs 603896 |
| Royalty Pharma plc RPRX | $68.53 | $19.01 | −72% | vs 603896 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Zhejiang Shouxiangu Pharm Co (603896) overvalued or undervalued?
What is the fair value of 603896?
What is the quality score of 603896?
What is the price target for Zhejiang Shouxiangu Pharm Co (603896)?
What is the Zhejiang Shouxiangu Pharm Co stock forecast for 2026?
What is the revenue of Zhejiang Shouxiangu Pharm Co (603896)?
Does Zhejiang Shouxiangu Pharm Co pay a dividend?
How much is the dividend of Zhejiang Shouxiangu Pharm Co (603896)?
What is the intrinsic value of Zhejiang Shouxiangu Pharm Co (603896)?
Is Zhejiang Shouxiangu Pharm Co stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 603896?
How much is Zhejiang Shouxiangu Pharm Co worth?
What do the bullish and bearish scenarios say about 603896?
How solid is the balance sheet of Zhejiang Shouxiangu Pharm Co (603896)?
How far is 603896 from its 52-week high?
Which stocks are comparable to Zhejiang Shouxiangu Pharm Co?
Is Zhejiang Shouxiangu Pharm Co stock attractive at the current price?
How is the fair value of 603896 calculated?
Is it still worth investing in stocks now?
What is the share price of Zhejiang Shouxiangu Pharm Co (603896)?
What should I pay attention to with Zhejiang Shouxiangu Pharm Co right now?
Where does the earnings growth of Zhejiang Shouxiangu Pharm Co (603896) come from?
Key figures of Zhejiang Shouxiangu Pharm Co
How large is the market capitalisation of Zhejiang Shouxiangu Pharm Co (603896)?
What is the P/S ratio of Zhejiang Shouxiangu Pharm Co (603896)?
What are the earnings per share of Zhejiang Shouxiangu Pharm Co (603896)?
What is the dividend yield of Zhejiang Shouxiangu Pharm Co (603896)?
What is the net margin of Zhejiang Shouxiangu Pharm Co (603896)?
What is the return on equity of Zhejiang Shouxiangu Pharm Co (603896)?
What is the EBIT return on assets of Zhejiang Shouxiangu Pharm Co (603896)?
What is the operating margin of Zhejiang Shouxiangu Pharm Co (603896)?
How fast is revenue growing at Zhejiang Shouxiangu Pharm Co (603896)?
How fast are earnings growing at Zhejiang Shouxiangu Pharm Co (603896)?
How much free cash flow does Zhejiang Shouxiangu Pharm Co (603896) generate?
How much net cash does Zhejiang Shouxiangu Pharm Co (603896) hold?
Watch Zhejiang Shouxiangu Pharm Co in the live analysis
One click puts Zhejiang Shouxiangu Pharm Co on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.